You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Protesome inhibitors

Showing 1 - 25 of 4,140
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Novel Drugs After Allo-HSCT in Patients With Multiple Myeloma

Recruiting
  • Multiple Myeloma
  • Stem Cell Transplant
    • Firenze, Italy
    • +1 more
    Aug 19, 2021

    CLL/SLL Trial (lisaftoclax +BTK inhibitor, BTK inhibitor)

    Not yet recruiting
    • CLL/SLL
    • lisaftoclax +BTK inhibitor
    • BTK inhibitor
    • (no location specified)
    Oct 26, 2023

    Acute Myeloid Leukemia Trial in Nanjing (Venclexta 100 MG Oral Tablet)

    Recruiting
    • Acute Myeloid Leukemia
    • Venclexta 100 MG Oral Tablet
    • Nanjing, Jiangsu, China
      The First Affiliated Hospital with Nanjing Medical University
    Jun 11, 2023

    Myelofibrosis Trial in Jinan (TQ05105 tablets, Itraconazole capsule, Rifampicin Capsule)

    Not yet recruiting
    • Myelofibrosis
    • TQ05105 tablets
    • +2 more
    • Jinan, Shandong, China
      Shandong Provincial Hospital
    Aug 30, 2023

    Advanced Breast Cancer Trial in Beijing (The combination of Dalpiciclib with physician-selected endocrine therapy, Chemotherapy

    Recruiting
    • Advanced Breast Cancer
    • The combination of Dalpiciclib with physician-selected endocrine therapy
    • Chemotherapy selected by the physician
    • Beijing, Beijing, China
      Peking Union Medical College Hospital
    May 22, 2023

    Musculoskeletal Health in Breast Cancer During Aromatase

    Recruiting
    • Musculoskeletal Health
    • No intervention
    • Shanghai, Shanghai, China
      School of Nursing, Fudan University
    Jun 16, 2023

    SGLT-2 Inhibitors on Epicardial Adipose Tissue and Cardiac

    Recruiting
    • Coronary Artery Disease
    • Sodium Glucose Co-transporter 2 (SGLT2) Inhibitor
    • Shah Alam, Selangor, Malaysia
      Institute for Clinical Research, National Institutes of Health,
    Nov 9, 2023

    Bile Acids in Acute Insulin Resistance

    Recruiting
    • PI3K Gene Mutation
    • +4 more
    • Drug-induced acute insulin resistance due to PI3K inhibitor, AKT inhibitor, or mTOR inhibitor
    • New York, New York
      Columbia University Medical Center
    Oct 6, 2022

    ICIs Plus Angiogenesis Inhibitors for Treatment of Advanced

    Completed
    • NSCLC
    • Immune checkpoint inhibitors plus angiogenesis inhibitors
    • Immune checkpoint inhibitors without angiogenesis inhibitors
    • Suzhou, Jiangsu, China
      The Affiliated Suzhou Hospital of Nanjing Medical University
    Jan 17, 2023

    Breast Feeding, Hypertension, Heart Failure Trial in Leuven (Venipuncture)

    Recruiting
    • Breast Feeding
    • +3 more
    • Venipuncture
    • Leuven, Vlaams-Brabant, Belgium
      Universitaire Ziekenhuizen Leuven
    Oct 12, 2023

    Acute Esophageal Variceal Hemorrhage Trial in Hanzhou (Growth Inhibitor)

    Recruiting
    • Acute Esophageal Variceal Hemorrhage
    • Growth Inhibitor
    • Hanzhou, Zhejiang, China
      2nd Affiliated Hospital, School of Medicine, Zhejiang University
    Aug 22, 2023

    Heart Failure, Heart Failure With Reduced Ejection Fraction Trial in Danville (Pharmacist co-management, CDS, Focused Education)

    Recruiting
    • Heart Failure
    • Heart Failure With Reduced Ejection Fraction
    • Pharmacist co-management
    • +2 more
    • Danville, Pennsylvania
      Geisinger Cardiology Clinics
    Aug 11, 2023

    Gastroesophageal Reflux, Regurgitation, Heartburn Trial in Jacksonville (Breath Testing)

    Not yet recruiting
    • Gastroesophageal Reflux
    • +2 more
    • Breath Testing
    • Jacksonville, Florida
      Mayo Clinic Florida
    Jul 27, 2023

    Hepatocellular Carcinoma, Recurrence, Immune Checkpoint Inhibitor Trial in Nanning (Adjuvant tislelizumab plus lenvatinib,

    Not yet recruiting
    • Hepatocellular Carcinoma
    • +2 more
    • Adjuvant tislelizumab plus lenvatinib
    • Adjuvant tislelizumab
    • Nanning, China
      Jian-Hong Zhong
    Jun 11, 2023

    Cancer of the Colon Trial in Marseille (BLOOD AND TUMOR)

    Recruiting
    • Cancer of the Colon
    • BLOOD AND TUMOR
    • Marseille, France
      Institut Paoli Calmettes
    Jul 12, 2023

    Gastric Adenocarcinoma Trial (cadonilimab combined +paclitaxel (albumin-bound))

    Not yet recruiting
    • Gastric Adenocarcinoma
    • cadonilimab combined +paclitaxel (albumin-bound)
    • (no location specified)
    Nov 1, 2023

    SGLT-2 Inhibitors in the Treatment of Ascites

    Recruiting
    • Ascites Hepatic
    • +2 more
    • SGLT2 inhibitor
    • Palermo, Italy
    • +1 more
    Aug 11, 2023

    Metastatic Breast Cancer, Advanced Breast Cancer, Quality of Life Trial in Worldwide (CDK 4/6 inhibitors, Endocrine therapy)

    Not yet recruiting
    • Metastatic Breast Cancer
    • +4 more
    • CDK 4/6 inhibitors
    • Endocrine therapy
    • Helsinki, Finland
    • +11 more
    Sep 19, 2023

    Breast Cancer Stage IV Trial in Mansoura (comparing both arms as regard the objective response rate, toxicity profile, quality

    Recruiting
    • Breast Cancer Stage IV
    • comparing both arms as regard the objective response rate, toxicity profile, quality of life, progression free survival
    • Mansoura, Dakahlia, Egypt
      Oncology center mansoura university
    Jan 1, 2023

    Type 2 Diabetes, Blood Glucose Fluctuation Trial in Nanjing (Metformin plus pioglitazone, Acarbose)

    Recruiting
    • Type 2 Diabetes
    • Blood Glucose Fluctuation
    • Nanjing, China
      Nanjing First Hospital, Nanjing Medical Univesity
    Nov 28, 2022

    Checkpoint Inhibitors in Solid Tumors:Retrospective Real-world

    Recruiting
    • Immunotherapy
      • Nanjing, Jiangsu, China
        The First Affiliated Hospital with Nanjing Medical University
      Feb 8, 2023

      Fruquintinib With PD-1 Inhibitors Versus TAS-102 With

      Completed
      • Metastatic Colorectal Adenocarcinoma
      • Changsha, Hunan, China
        Hunan Cancer hospital
      Sep 2, 2023

      Gynecologic Cancer, Carcinoma, Uterine Cancer Trial in Birmingham (Cabo + Dostarlimab)

      Not yet recruiting
      • Gynecologic Cancer
      • +3 more
      • Cabo + Dostarlimab
      • Birmingham, Alabama
        O'Neal Comprehensive Cancer Center at UAB
      Jan 10, 2023

      Chronic Phase Chronic Myelogenous Leukemia, BCR-ABL1 Positive Trial in Worldwide (procedure, other, drug)

      Recruiting
      • Chronic Phase Chronic Myelogenous Leukemia, BCR-ABL1 Positive
      • Biospecimen Collection
      • +4 more
      • Birmingham, Alabama
      • +170 more
      Jan 30, 2023

      Sodium Glucose Cotransporter 2 Inhibitiors on Left Ventricular

      Not yet recruiting
      • SGLT2 Inhibitiors Remodeling Effect
      • Chronic Heart Disease
      • Sodium-glucose cotransporter 2 inhibitor
      • (no location specified)
      Nov 14, 2023